TP53 and neoplasm: As an illustration, when delivering potent tumor suppressors (Tp53 and Cdkn2a) targeted sgRNAs and Cas in GEMM liver, tumor formations were only observed when additional triggers existed, including Kras G12D mutation and CCl4 related inflammation.346